Feng, Yuan
Li, Yanjie
Xu, Mingxing
Meng, Hongyu
Dai, Cao
Yao, Zhicheng
Funding for this research was provided by:
national natural science foundation of china (82002544, 81760112, 82100560)
science and technology planning project of guangzhou city (202102010171)
chinese foundation for hepatitis prevention and control-tianqing liver disease research fund subject (TQGB20200048)
csco-roche solid tumor research project (Y-Roche2019/2-0041)
medical scientific research foundation of guangdong province (A2021110)
Article History
Received: 29 July 2021
Accepted: 20 July 2022
First Online: 28 July 2022
Declarations
:
: This experiment was approved by the ethical committee of Guangzhou Forevergen Biosciences (Guangzhou, China).
: Not applicable.
: The authors declare no competing interests.